Therapeutic approach of histamine H3 receptors in obesity.
Obesity is considered one of the risk factors for metabolic disorders. There is increasing evidence that obesity is under control of several cytokines and hormone in the brain. Brain histamine and H3 receptors are important factors for regulating obesity. The results of physiological and pharmacological studies revealed that brain histamine and H3 receptors are involved in the regulation of obesity. In this review, we describe the implication and patent for developing H3 receptor antagonists and their therapeutic potential of obesity.
Masaki
Takayuki
T
Department of Internal Medicine 1, Faculty of Medicine, Oita University,Yufu-Hasama, Oita, Japan. masaki@med.oita-u.ac.jp
Yoshimatsu
Hironobu
H
D000818:Animals; D006632:Histamine / Q000378:metabolism; D006633:Histamine Antagonists / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism*; D018100:Receptors, Histamine H3 / Q000502:physiology*
D006633:Histamine Antagonists; D018100:Receptors, Histamine H3; D006632:Histamine